Inhibition of interferon gene activation bydeath-effector domain-containing proteins from the molluscum contagiosum virus

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 2, 2014, Pages

  Randall, Crystal M H ^a   Biswas, Sunetra ^a   Selen, Catherine V ^a   Shisler, Joanna L ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Host pathogen interactions; Immune evasion

Indexed keywords

DEATH EFFECTOR DOMAIN CONTAINING PROTEIN; I KAPPA B KINASE EPSILON; INTERFERON REGULATORY FACTOR 3; LUCIFERASE; PROTEIN MC159; PROTEIN MC160; PROTEIN TBK1; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; DOWN REGULATION; GENE ACTIVATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOPRECIPITATION; MOLLUSCUM CONTAGIOSUM; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SKIN INFECTION; UPREGULATION; VIRUS PATHOGENESIS;

HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION;

HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; I-KAPPA B KINASE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTERFERON-BETA; LUCIFERASES; MOLLUSCUM CONTAGIOSUM; MOLLUSCUM CONTAGIOSUM VIRUS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; VIRAL PROTEINS;

EID: 84892583254     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1314569111     Document Type: Article

References (71)

1. Sadler AJ, Williams BR (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559-568.
2. Müller U, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264(5167):1918-1921.
3. Seth RB, Sun L, Ea CK, Chen ZJ (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122(5):669-682.
4. Kawai T, et al. (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6(10):981-988.
5. Yoneyama M, et al. (2004) The RNA helicase RIG-I has an essential function in doublestranded RNA-induced innate antiviral responses. Nat Immunol 5(7):730-737.
6. Hornung V, et al. (2006) 5?-Triphosphate RNA is the ligand for RIG-I. Science 314(5801):994-997.
7. Pichlmair A, et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5?-phosphates. Science 314(5801):997-1001.
8. Kato H, et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441(7089):101-105.
9. Oganesyan G, et al. (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439(7073):208-211.
10. Sharma S, et al. (2003) Triggering the interferon antiviral response through an IKKrelated pathway. Science 300(5622):1148-1151.
11. Fitzgerald KA, et al. (2003) IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4(5):491-496.
12. Nakhaei P, Hiscott J, Lin R (2010) STING-ing the antiviral pathway. J Mol Cell Biol 2(3): 110-112.
13. Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455(7213):674-678.
14. Randall RE, Goodbourn S (2008) Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89(Pt 1):1-47.
15. Senkevich TG, et al. (1996) Genome sequence of a human tumorigenic poxvirus: prediction of specific host response-evasion genes. Science 273(5276):813-816.
16. Randall CMH, Shisler J (2013) Molluscum contagiosum virus: Persistence pays off. Future Virology 8(6):561-573.
17. Waibler Z, et al. (2009) Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components. J Virol 83(4):1563-1571.
18. Myskiw C, Arsenio J, van Bruggen R, Deschambault Y, Cao J (2009) Vaccinia virus E3 suppresses expression of diverse cytokines through inhibition of the PKR, NF-kappaB, and IRF3 pathways. J Virol 83(13):6757-6768.
19. Zurkova K, et al. (2009) The expression of the soluble isoform of hFlt3 ligand by recombinant vaccinia virus enhances immunogenicity of the vector. Oncol Rep 21(5): 1335-1343.
20. Deng L, et al. (2008) Vaccinia virus subverts a mitochondrial antiviral signaling protein- dependent innate immune response in keratinocytes through its doublestranded RNA binding protein, E3. J Virol 82(21):10735-10746.
21. Domingo-Gil E, Pérez-Jiménez E, Ventoso I, Nájera JL, Esteban M (2008) Expression of the E3L gene of vaccinia virus in transgenic mice decreases host resistance to vaccinia virus and Leishmania major infections. J Virol 82(1):254-267.
22. Unterholzner L, et al. (2011) Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 7(9): e1002247.
23. Ferguson BJ, et al. (2013) Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol 94(Pt 9):2070-2081.
24. Xiang Y, Moss B (1999) IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc Natl Acad Sci USA 96(20):11537-11542.
25. Xiang Y, Moss B (2003) Molluscum contagiosum virus interleukin-18 (IL-18) binding protein is secreted as a full-length form that binds cell surface glycosaminoglycans through the C-terminal tail and a furin-cleaved form with only the IL-18 binding domain. J Virol 77(4):2623-2630.
26. Damon IK (2007) Poxviruses. Fields Virology, eds Knipe D, Howley P (Lippincott Williams & Wilkins, Philadelphia), 5th Ed, Vol 2, pp 2947-2976.
27. Bertin J, et al. (1997) Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 94(4): 1172-1176.
28. Irmler M, et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388(6638):190-195.
29. Hu S, Vincenz C, Buller M, Dixit VM (1997) A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor- 1-induced apoptosis. J Biol Chem 272(15):9621-9624.
30. Thome M, et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386(6624):517-521.
31. Shisler JL, Moss B (2001) Molluscum contagiosum virus inhibitors of apoptosis: The MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 282(1):14-25.
32. Chaudhary PM, et al. (2000) Activation of the NF-kappaB pathway by caspase 8 and its homologs. Oncogene 19(39):4451-4460.
33. Sun Q, Zachariah S, Chaudhary PM (2003) The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. J Biol Chem 278(52):52437-52445.
34. Matta H, et al. (2007) Kaposi?s sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaBwithout JNK activation. J Biol Chem 282(34):24858-24865.
35. Matta H, Sun Q, Moses G, Chaudhary PM (2003) Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-kappaB activation. J Biol Chem 278(52):52406-52411.
36. Kataoka T, et al. (2000) The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10(11):640-648.
37. Field N, et al. (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 116(Pt 18):3721-3728.
38. Nichols DB, Shisler JL (2006) The MC160 protein expressed by the dermatotropic poxvirus molluscum contagiosum virus prevents tumor necrosis factor alpha-induced NF-kappaB activation via inhibition of I kappa kinase complex formation. J Virol 80(2): 578-586.
39. Nichols DB, Shisler JL (2009) Poxvirus MC160 protein utilizes multiple mechanisms to inhibit NF-kappaB activation mediated via components of the tumor necrosis factor receptor 1 signal transduction pathway. J Virol 83(7):3162-3174.
40. Murao LE, Shisler JL (2005) The MCV MC159 protein inhibits late, but not early, events of TNF-α-induced NF-?B activation. Virology 340(2):255-264.
41. Randall CM, Jokela JA, Shisler JL (2012) The MC159 protein from the molluscum contagiosum poxvirus inhibits NF-?B activation by interacting with the I?B kinase complex. J Immunol 188(5):2371-2379.
42. Gil J, Rullas J, Alcam? J, Esteban M (2001) MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKR. J Gen Virol 82(Pt 12):3027-3034.
43. Balachandran S, Venkataraman T, Fisher PB, Barber GN (2007) Fas-associated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 178(4):2429-2439.
44. Maniatis T, et al. (1998) Structure and function of the interferon-beta enhanceosome. Cold Spring Harb Symp Quant Biol 63:609-620.
45. Panne D (2008) The enhanceosome. Curr Opin Struct Biol 18(2):236-242.
46. Handa P, Tupper JC, Jordan KC, Harlan JM (2011) FLIP (Flice-like inhibitory protein) suppresses cytoplasmic double-stranded-RNA-induced apoptosis and NF-?B and IRF3- mediated signaling. Cell Commun Signal 9:16.
47. Sato M, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13(4):539-548.
48. Challa S, Woelfel M, Guildford M, Moquin D, Chan FK (2010) Viral cell death inhibitor MC159 enhances innate immunity against vaccinia virus infection. J Virol 84(20): 10467-10476.
49. Shi X, et al. (2011) Endoribonuclease activities of porcine reproductive and respiratory syndrome virus nsp11 was essential for nsp11 to inhibit IFN-? induction. Mol Immunol 48(12-13):1568-1572.
50. Sun Y, Han M, Kim C, Calvert JG, Yoo D (2012) Interplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virus. Viruses 4(4):424-446.
51. Ning S, Pagano JS, Barber GN (2011) IRF7: Activation, regulation, modification and function. Genes Immun 12(6):399-414.
52. Helgason E, Phung QT, Dueber EC (2013) Recent insights into the complexity of Tankbinding kinase 1 signaling networks: The emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett 587(8):1230-1237.
53. Garvey T, Bertin J, Siegel R, Lenardo M, Cohen J (2002) The death effector domains (DEDs) of the molluscum contagiosum virus MC159 v-FLIP protein are not functionally interchangeable with each other or with the DEDs of caspase-8. Virology 300(2): 217-225.
54. Garvey TL, et al. (2002) Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J Virol 76(2): 697-706.
55. Thurau M, Everett H, Tapernoux M, Tschopp J, Thome M (2006) The TRAF3-binding site of human molluscipox virus FLIP molecule MC159 is critical for its capacity to inhibit Fas-induced apoptosis. Cell Death Differ 13(9):1577-1585.
56. Tyring SK (2003) Molluscum contagiosum: The importance of early diagnosis and treatment. Am J Obstet Gynecol 189(3, Suppl):S12-S16.
57. Konya J, Thompson CH (1999) Molluscum contagiosum virus: Antibody responses in persons with clinical lesions and seroepidemiology in a representative Australian population. J Infect Dis 179(3):701-704.
58. Birthistle K, Carrington D (1997) Molluscum contagiosum virus. J Infect 34(1):21-28.
59. Watanabe T, et al. (2000) Antibodies to molluscum contagiosum virus in the general population and susceptible patients. Arch Dermatol 136(12):1518-1522.
60. Ma Y, et al. (2012) Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection. J Virol 86(4):2188-2196.
61. Zhang M, et al. (2012) TRAF-interacting protein (TRIP) negatively regulates IFN-? production and antiviral response by promoting proteasomal degradation of TANKbinding kinase 1. J Exp Med 209(10):1703-1711.
62. Sears N, Sen GC, Stark GR, Chattopadhyay S (2011) Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation. J Biol Chem 286(38):33037-33044.
63. Liu XY, Wei B, Shi HX, Shan YF, Wang C (2010) Tom70 mediates activation of interferon regulatory factor 3 on mitochondria. Cell Res 20(9):994-1011.
64. Yang K, et al. (2006) Hsp90 regulates activation of interferon regulatory factor 3 and TBK-1 stabilization in Sendai virus-infected cells. Mol Biol Cell 17(3):1461-1471.
65. Tamura T, Yanai H, Savitsky D, Taniguchi T (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535-584.
66. Murtaza I, Saleem M, Adhami VM, Hafeez BB, Mukhtar H (2009) Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells. Cancer Res 69(3):1156-1165.
67. Medema JP, de Jong J, van Hall T, Melief CJ, Offringa R (1999) Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J Exp Med 190(7): 1033-1038.
68. Lee TJ, Lee JT, Park JW, Kwon TK (2006) Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation. Biochem Biophys Res Commun 351(4):1024-1030.
69. Shisler JL, Senkevich TG, Berry MJ, Moss B (1998) Ultraviolet-induced cell death blocked by a selenoprotein from a human dermatotropic poxvirus. Science 279(5347): 102-105.
70. Chaudhary PM, Jasmin A, Eby MT, Hood L (1999) Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18(42):5738-5746.
71. Yang JK, et al. (2005) Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition. Mol Cell 20(6):939-949.